The inhibitory action of the antimigraine nonsteroidal anti-inflammatory drug naproxen on P2X3 receptor-mediated responses in rat trigeminal neurons by Hautaniemi T. et al.
THE INHIBITORY ACTION OF THE ANTIMIGRAINE NONSTEROIDAL
ANTI-INFLAMMATORY DRUG NAPROXEN ON P2X3 RECEPTOR-
MEDIATED RESPONSES IN RAT TRIGEMINAL NEURONS
T. HAUTANIEMI,a1 N. PETRENKO,a1
A. SKORINKINb AND R. GINIATULLINa*
aDepartment Neurobiology, A. I. Virtanen Institute for Molecular Sci-
ences, University of Eastern, Finland
bKazan Federal University and Kazan Institute of Biochemistry and
Biophysics, Kazan, Russia
Abstract—Enhanced nociceptive firing in trigeminal ganglion
neurons is a likely reason for migraine pain. In experimental
migraine-like conditions induced by the calcitonin gene-re-
lated peptide (CGRP), P2X3 receptors abundantly expressed
in trigeminal neurons are highly responsive to the excitatory
action of extracellular ATP. In this study, we tested whether
naproxen, a common antimigraine medicine, could affect the
function of P2X3 receptors in the presence or absence of the
algogen nerve growth factor (NGF), the level of which is
elevated in patients with chronic migraine. We used calcium
imaging and patch clamp recordings from rat trigeminal neu-
rons, which were activated by a relative specific P2X3 agonist
,-meATP or by high potassium-induced depolarization. In
the absence of NGF, naproxen dose-dependently (0.1–1 mM)
reduced intracellular calcium transients elicited by ,-
meATP. Naproxen also led to a slight, but significant, reduc-
tion in calcium transients induced by potassium ions, indi-
cating the involvement of voltage-gated calcium channels.
The inhibitory action of 1 mM naproxen was enhanced after
NGF pretreatment, suggesting that P2X3 receptors in sensi-
tized neurons are more susceptible to inhibition by high
doses of this nonsteroidal anti-inflammatory drug (NSAID).
Using patch clamp recordings from HEK293 cells expressing
P2X3 receptors, we tested the direct action of naproxen on
P2X3 receptor-mediated membrane currents. In clinically rel-
evant concentrations of 0.5 mM, naproxen produced a use-
dependent blocking effect on ATP receptors. Kinetic analysis
suggests that naproxen inhibited P2X3 receptors via facilita-
tion of fast desensitization, which determines current decay
in the continuous presence of the agonist. In summary, we
present a novel fast mechanism for the antimigraine action of
naproxen, which can act in synergy with the cyclooxygenase
inhibition to attenuate headaches. © 2012 IBRO. Published by
Elsevier Ltd. All rights reserved.
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Naproxen is one of most commonly used medicines for
treatment of migraine attack. In combination with su-
matriptan, naproxen has been suggested as the most ef-
ficient medicine for acute treatment of migraine (Brandes
et al., 2007). Naproxen is a nonsteroidal anti-inflammatory
drug (NSAID) belonging to a group of profens that are
nonselective inhibitors of both types 1 and 2 cyclooxygen-
ase (COX-1/2) (Duggan et al., 2010). The main mecha-
nism of its analgesic action is thought to be the inhibition of
COX-dependent synthesis of proinflammatory algogenic
prostaglandins and oxygenated endocannabinoids (Kozak
et al., 2004). However, NSAIDs are reported to have sev-
eral other effects within the nociceptive system. For exam-
ple, the NSAIDs diclofenac and ibuprofen have been found
to inhibit acid-sensing ion channels in hippocampal in-
terneurons (Dorofeeva et al., 2008) and in sensory neu-
rons (Voilley et al., 2001).
Naproxen has been shown to inhibit trigeminal neuro-
nal firing, which is activated through the in vivo application
of “inflammatory soup” onto the dura mater (Jakubowski et
al., 2007; Levy et al., 2008). However, the mechanism of
the inhibitory action on neuronal firing by this COX inhibitor
remains unexplained.
Extracellular ATP is the one of the most potent algo-
gens that can initiate pain signaling via membrane P2X2/3
or P2X3 receptors expressed in sensory neurons (North,
2004). ATP-gated P2X3 receptors have recently been im-
plicated in migraines (for review see Giniatullin et al., 2008
and Burnstock et al., 2011). The responsiveness of P2X3
receptors in rat trigeminal neurons could be largely en-
hanced by the migraine mediator calcitonin gene-related
peptide (CGRP) (Fabbretti et al., 2006) consistent with
“purinergic” mechanisms of migraine pain (Giniatullin et al.,
2008). The powerful algogen nerve growth factor (NGF),
which is elevated in patients with chronic migraine (Jang et
al., 2011), also strongly potentiates P2X3 receptor-medi-
ated responses in trigeminal neurons via protein kinase
C-dependent phosphorylation (D’Arco et al., 2007).
In the current study, we show that the P2X3 receptor
represents one of the targets for the depressant action of
naproxen in pain signaling.
EXPERIMENTAL PROCEDURES
Cell cultures and transfection
The trigeminal ganglion neurons of P10–12 male rats were pre-
pared for culture, as previously described (Simonetti et al., 2006;
Mazzuca et al., 2011). All efforts were made to minimize the
number of animals used and their suffering. Briefly, neurons were
plated on coverslips coated in poly-L-lysine (0.2 mg/ml) and cul-
tured for 1–2 days at 37 °C in an atmosphere containing 5% CO2.
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